Back to results
US 2006/0039906 A1Published application
Humanized antibodies that sequester abeta peptide
OwnerDavid Holtzman, Ronald DeMattos +4inventors
InventorsDavid Holtzman, Ronald DeMattos, Kelly Bales, Steven Paul, Naoya Tsurushita, Maximiliano Vasquez
Life of this patent
Estimating the term…
Abstract
A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble Aβ peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide Aβ.
Claims21
1-45. (canceled)
An immunologically effective fragment of a humanized antibody, wherein the humanized antibody comprises:
- a. a light chain comprising three light chain complementarity determining regions (CDRs) having the following amino acid sequences:
- light chain CDR1:
- (SEQ ID NO:1)
- 1 5 10 15
- Arg Ser Ser Gln Ser Leu Ile Tyr Ser Asp Gly Asn Ala Tyr Leu His;
- or
- (SEQ ID NO:15)
- 1 5 10 15
- Arg Ser Ser Gln Ser Leu Val Tyr Ser Asp Gly Asn Ala Tyr Leu His
- light chain CDR2:
- 1 5
- Lys Val Ser Asn Arg Phe Ser
- (SEQ ID NO:2)
- and, light chain CDR3:
- 1 5
- Ser Gln Ser Thr His Val Pro Trp Thr
- (SEQ ID NO:3)
- and a light chain framework sequence from a humanized immunoglobulin light chain;
- and
- b. a heavy chain comprising three heavy chain CDRs having the following amino acid sequences:
- heavy chain CDR1:
- 1 5
- Arg Tyr Ser Met Ser
- (SEQ ID NO:4)
- heavy chain CDR2:
- (SEQ ID NO:5)
- 1 5 10 15
- Gln Ile Asn Ser Val Gly Asn Ser Thr Tyr Tyr Pro Asp Thr Val Lys Gly;
- or
- (SEQ ID NO:16)
- 1 5 10 15
- Gln Ile Asn Ser Val Gly Asn Ser Thr Tyr Tyr Pro Asp Ser Val Lys Gly
- and, heavy chain CDR3:
- 1
- Gly Asp Tyr
- (SEQ ID NO:6)
- and a heavy chain framework sequence from a humanized immunoglobulin heavy chain.
34 more elements
Dependencies are inferred from the claim text.